Peritoneal Dialysis Market Research 2024-2034: Growing Prevalence of Chronic Diseases Underscores Need for Dialysis Innovations [Yahoo! Finance]
Baxter to Present at 43rd Annual J.P. Morgan Healthcare Conference
The Global Market for Motion Sickness Treatment, 2024-2030: Increasing Preference for OTC Solutions Strengthens Business Case [Yahoo! Finance]
Moon Surgical Appoints Chris Toth as Independent Board Member Ahead of Commercial Acceleration [Yahoo! Finance]
Baxter International Inc. (NYSE: BAX) had its price target lowered by analysts at Citigroup Inc. from $37.00 to $35.00. They now have a "neutral" rating on the stock.